Abbott a new overweight at Piper Sandler; at attractive entry point [Seeking Alpha]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Seeking Alpha
The firm has a price target of $131 (14% upside based on Sept. 19 close). Analyst Adam Maeder said that while the stock's performance has underwhelmed due to litigation over bowel disease caused by allegedly tainted Abbott baby formula products, he doesn't see much top-line risk associated with this, adding that the Street is likely pricing in damages related to the cases. He added he sees a path forward for durable top-line growth and is poised for double-digit adjusted EPS growth in 2025 and beyond. "We couple this financial profile with a consistent dividend and solid past track record in recessionary environments and, ultimately, we see a versatile large-cap name that's undervalued," Maeder wrote. Recommended For You More Trending News Recommended For You More Trending News About ABT Stock Related Stocks Trending Analysis Trending News
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- AI is Redefining the Hepatitis B and C Diagnostics Market, Set to Grow by USD 3.02 Billion from 2024-2028 with Rising Demand for Molecular Diagnostics - Technavio [Yahoo! Finance]Yahoo! Finance
- Abbott Declares 403rd Consecutive Quarterly DividendPR Newswire
- Jim Cramer: Don't let Abbott Labs' litigation overhang keep you out of the stock [CNBC]CNBC
- Abbott Laboratories (NYSE: ABT) is now covered by analysts at Piper Sandler Companies. They set an "overweight" rating and a $131.00 price target on the stock.MarketBeat
- Abbott Laboratories' (NYSE:ABT) Stock Been Rising: Are Strong Financials Guiding The Market? [Yahoo! Finance]Yahoo! Finance
ABT
Earnings
- 7/18/24 - Beat
ABT
Sec Filings
- 9/13/24 - Form 4
- 9/12/24 - Form 144
- 9/4/24 - Form 4
- ABT's page on the SEC website